Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2

Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor

(2015) Haruo Kato et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Metformin effects on biochemical recurrence and metabolic signaling in the prostate

(2015) Brian Winters et al.   PROSTATE

Metformin and erlotinib synergize to inhibit basal breast cancer

(2015) Ying-Ka Ingar Lau et al.   Oncotarget

Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling

(2014) Roberta Malaguarnera et al.   ENDOCRINOLOGY

Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2

(2013) K M Biernacka et al.   ENDOCRINE-RELATED CANCER

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan

(2012) Chin-Hsiao Tseng   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality

(2012) Daniel E. Spratt et al.   EUROPEAN UROLOGY

Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer

(2012) A J Colquhoun et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients

(2011) X.- X. He et al.   ANNALS OF ONCOLOGY

Influence of obesity on tumour volume in patients with prostate cancer

(2011) Umberto Capitanio et al.   BJU INTERNATIONAL

Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer

(2011) Min Han Tan et al.   BREAST CANCER RESEARCH AND TREATMENT

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel

(2011) C C Uzoh et al.   BRITISH JOURNAL OF CANCER

Obesity and Prostate Cancer Aggressiveness among African and Caucasian Americans in a Population-Based Study

(2011) L. J. Su et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer: A retrospective cohort study of older Medicare patients

(2011) N. E. Morden et al.   DIABETES CARE

Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies

(2011) S. C. Larsson et al.   DIABETOLOGIA

Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)

(2011) Anne T. Nies et al.   PLoS One

Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Cα-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activat

(2010) Yong P Hwang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Diabetes Genes and Prostate Cancer in the Atherosclerosis Risk in Communities Study

(2010) T. E. Meyer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal Function: Clinical recommendations

(2010) A. Frid et al.   DIABETES CARE

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase

(2010) Carolyn Algire et al.   ENDOCRINE-RELATED CANCER

Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo

(2010) C Algire et al.   ONCOGENE

Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study

(2009) Jonathan L. Wright et al.   CANCER CAUSES & CONTROL

New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes

(2009) G. Libby et al.   DIABETES CARE

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study

(2008) T. J. Murtola et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase

(2008) M. Zakikhani et al.   Cancer Prevention Research

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

(2008) I Ben Sahra et al.   ONCOGENE